发文地区与机构
近年国家 / 地区发文量统计
| 国家 / 地区 | 发文量 |
|---|---|
| USA | 5492 |
| Canada | 597 |
| Japan | 266 |
| CHINA MAINLAND | 235 |
| Italy | 176 |
| Spain | 153 |
| GERMANY (FED REP GER) | 147 |
| England | 135 |
| France | 124 |
| Netherlands | 118 |
近年机构发文量统计
| 机构 | 发文量 |
|---|---|
| HARVARD UNIVERSITY | 656 |
| UNIVERSITY OF TEXAS SYSTEM | 515 |
| MEMORIAL SLOAN KETTERING CANCER CENTER | 401 |
| UNIVERSITY OF CALIFORNIA SYSTEM | 389 |
| BRIGHAM & WOMEN'S HOSPITAL | 354 |
| MAYO CLINIC | 317 |
| JOHNS HOPKINS UNIVERSITY | 278 |
| MASSACHUSETTS GENERAL HOSPITAL | 269 |
| UNIVERSITY OF TORONTO | 256 |
| PENNSYLVANIA COMMONWEALTH SYSTEM OF HIG... | 232 |
文章引用情况
1
RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations2
Pattern multiplicity and fumarate hydratase (FH)/S-(2-succino)-cysteine (2SC) staining but not eosinophilic nucleoli with perinucleolar halos differentiate hereditary leiomyomatosis and renal cell carcinoma-associated renal cell carcinomas from kidney tumors without FH gene alteration3
Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas4
JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management5
Clinicopathologic characteristics of poorly differentiated chordoma6
Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/beta-catenin pathway7
Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays8
Combined mutation and copy-number variation detection by targeted next-generation sequencing in uveal melanoma9
Prevalence of recurrent oncogenic fusion in mismatch repair-deficient colorectal carcinoma with hypermethylated MLH1 and wild-type BRAF and KRAS10
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancer